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ABSTRACT Two distinct forms of desensitization have been characterized for N-methyl-D-aspartate (NMDA) receptors. One
form results from a weakening of agonist affinity when channels are activated whereas the other form of desensitization
results when channels enter a long-lived nonconducting state. A weakening of glycine affinity upon NMDA receptor activation
has been reported. Cyclic reaction schemes for NMDA receptor activation require that a concomitant affinity shift should be
observed for glutamate agonists. In this study, measurements of peak and steady-state NMDA receptor currents yielded EC50
values for glutamate that differed by 1.9-fold, but no differences were found for another agonist, L-cysteine-S-sulfate (LCSS).
Simulations show that shifts in EC50 values may be masked by significant degrees of desensitization resulting from channels
entering a long-lived nonconducting state. Simulations also show that a decrease in the degree of desensitization with
increasing agonist concentration is a good indicator for the existence of desensitization resulting from a weakening of agonist
affinity. Both glutamate and LCSS exhibited this trend. An affinity difference of three- to eightfold between high-and
low-affinity agonist-binding states was estimated from fitting of dose-response data with models containing both types of
desensitization. This indicates that activation of NMDA receptors causes a reduction in both glutamate and glycine affinities.
INTRODUCTION
N-methyl-D-aspartate (NMDA) receptor ion channels are
one of the postsynaptic targets of glutamate-mediated syn-
aptic transmission in the mammalian brain. NMDA recep-
tors play a key role in physiological processes such as
development and modification of synaptic plasticity by al-
lowing glutamate-gated calcium influx into neuronal cells
(for review see Dingledine et al., 1999; Ozawa et al., 1998).
For channel opening to be achieved, NMDA receptor chan-
nels require the binding of two different types of agonist:
glutamate and glycine (Kleckner and Dingledine, 1988).
Activation of NMDA receptors that have been pre-equili-
brated with glycine, by a pulse of nearly saturating NMDA
(100 M) produced a peak current that decayed or desen-
sitized to a steady-state level during the NMDA pulse. The
degree of desensitization during the NMDA pulse was in-
versely dependent on the degree of saturation of the glycine-
binding site and may result from a weakening of glycine
affinity upon channel activation (Benveniste et al., 1990;
Mayer et al., 1989; Vyklicky et al., 1990)
Shown below is a simple reaction scheme for NMDA
activation (Benveniste et al., 1990) that can explain inde-
pendent binding of both glutamate- and glycine-binding site
agonists and can describe desensitization that can result
from a weakening of glycine-binding affinity:
(1)
R represents the receptor, Glu represents the glutamate-
binding site agonist (NMDA), Gly represents the glycine-
binding site agonist and Kmn represents the equilibrium
dissociation constants for the transition between states m
and n (states depicted in bold). Provided that KAB  KCD,
Scheme 1 can simulate the desensitization in the following
way. Before NMDA application, NMDA receptors pre-
equilibrated with glycine occupy states A and B. When
saturating concentrations of NMDA are applied, the reac-
tion scheme shifts rightward toward the open state of the
channel (E). At this stage, if glycine concentrations are
subsaturating, then a significant number of receptors will
occupy states C and D. The desensitization of macroscopic
currents can then be explained mechanistically as the re-
equilibration of glycine with its low-affinity-state binding
site (states C and D) after the sudden switch in receptor
occupancy from the higher-affinity states A and B to recep-
tor states C and D, which is induced by NMDA application.
If glycine binding affinities can exist in two affinity states
such that KAB is less than KCD, then the law of microscopic
reversibility (Colquhoun and Hawkes, 1995) requires that
KAC be less than KBD by the same degree. If this is true, then
it should be possible to find a type of desensitization that
results from a weakening of glutamate-binding affinity.
This paper shows that this type of desensitization exists and
thus generally reaffirms the basis for a cyclic reaction
scheme for NMDA receptor activation, strengthens the ar-
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guments for co-agonist affinity shifts upon receptor activa-
tion, and provides a starting point for in-depth study of the
reaction scheme for NMDA receptor activation.
MATERIALS AND METHODS
Dissociated neuronal cultures
The procedure for producing low-density rat hippocampal neuronal cul-
tures has been detailed previously (Nahum-Levy et al., 1999). In brief, 14
hippocampi from Sprague-Dawley postnatal day 1 rat pups were digested
with papain (100 units; Sigma Chemical Co., St. Louis, MO) for 20 min,
triturated to a single-cell suspension, and plated at a density of 75,000
cells/ml onto a 2-week-old glial feeder layer. The glial feeder layer was
derived from a similar dissection and grown on a substrate of bovine
collagen type IV and 100 g/ml poly-L-lysine in 35-mm2 dishes. Glia were
maintained in modified Eagle’s medium containing 2 mM glutamine, 4.5
g/L D-glucose, 10% fetal bovine serum, 100 U/ml penicillin, and 100
g/ml streptomycin. Neurons were maintained in a similar growth medium
containing 5% horse serum instead of fetal bovine serum and a neuronal
supplement N3 (Guthrie et al., 1987). Glial proliferation was arrested by
adding 20 M fluorodeoxyuridine and 51 M uridine. All cultures were
maintained at 36°C in humidified air containing 5% CO2.
Electrophysiology and rapid perfusion system
Whole-cell voltage clamp experiments were conducted utilizing an Axo-
patch 200A amplifier (Axon Instruments, Foster City, CA) at room tem-
perature between 1 and 2 weeks after neurons were plated. The extracel-
lular control solution consisted of 160 mM NaCl, 2.5 mM KCl, 0.2 mM
CaCl2, 10 mM glucose, 10 mM HEPES, 400 nM tetrodotoxin, 5 M
bicuculline methochloride, and 10 g/ml phenol red, adjusted to pH 7.3
and 325 mOsm. The intracellular solution consisted of 125 mM CsMeSO3,
15 mM CsCl, 0.5 mM CaCl2, 3 mM MgCl2, 5 mM Cs4BAPTA, and 2 mM
Na2ATP, adjusted to pH 7.2 and 305 mOsm.
The rapid drug perfusion apparatus has been described in detail previ-
ously (Nahum-Levy et al., 1999). Experimental solutions were continu-
ously perfused over the whole neuron from a flow pipe consisting of an
array of nine glass barrels (400 m o.d.) that was positioned 100 m
away from the neuronal soma. At a given moment, a stepper motor
positioned an adjacent barrel in front of the neuronal soma and a different
solution began to flow. The time constant for solution exchange around the
neuron (ex), has been determined by measuring the current rise from
hippocampal neurons elicited by a switch between two solutions containing
150 M kainate in which the NaCl concentration increases from 5 to 160
mM (Vyklicky et al., 1990). This time constant was 10 ms. Data were
acquired utilizing a Macintosh PPC 7600 computer with an ITC-16 analog-
to-digital converter (Instrutech Corp., Port Washington, NY). Synapse, a
Macintosh-based electrophysiological software package (Synergistic Sys-
tems, Silver Spring, MD) was used for controlling data acquisition and for
data analysis.
Although neurons are constantly perfused with an extracellular solution,
the hippocampal neuron-glial mixed culture system still secreted a signif-
icant amount of glycine agonist to elicit responses to 300 M NMDA in
the absence of added glycine. Responses are similar for concentrations of
added glycine 100 nM. Application of glutamate in the absence of
L-alanine also elicited inward currents. To reduce the possible influence of
channels entering desensitized states before the L-alanine pulse, glycine-
binding site low-affinity competitive antagonist, 5-methyl-indole-2-car-
boxylic acid (5MeI2CA) (Huettner, 1989) was added to all solutions
containing glutamate but lacking L-alanine. 5MeI2CA reduced the peak
response to the application of 10 M glutamate with no added glycine with
an IC50  1.2 mM and a Hill coefficient of 1.5 (n  5 cells). For
subsequent experiments 10 mM 5MeI2CA was used, which reduced peak
responses elicited by the addition of 10 M glutamate with no added
glycine to 1.1  0.6% (n  5 cells, data not shown) of the control
responses in the absence of 5MeI2CA. Low-affinity binding is highly
indicative of rapidly dissociating compounds; thus, it was expected that
5MeI2CA would dissociate within the time required for solution exchange.
Peak NMDA receptor responses elicited by a pulse of L-alanine in the
continual presence of a background concentration of 10 M glutamate
were not reduced; nor was the rise time of the L-alanine response slowed
by addition of 10 mM 5MeI2CA to the solutions not containing L-alanine
(data not shown).
Dose-response analysis
Standard dose-response analysis was done utilizing the Hill equation:
100
I
Ip,control
 100
Imax
1  EC50agonist
nH , (2)
where Imax is the maximal response, EC50 represents the concentration of
the half maximal response and nH is the Hill coefficient. I represents either
Ip or If, which are the peak and final current amplitudes, respectively. Ip is
defined as the maximal amplitude recorded within the first 500 ms of the
NMDA receptor response, whereas If is an average of the current during
the final 200 ms of the NMDA response. Both Ip and If must be normalized
to a standardized Ip response (i.e., 10 M for glutamate and 100 M for
LCSS) to compare responses between different experiments. Experimental
measurement of the degree of desensitization is:
Degree of desensitization 1
If
Ip
. (3)
Note that for this analysis, the degree of desensitization can be determined
from Ip and If values from each trace without normalization to a standard-
ized response. The degree of desensitization is only determined for those
concentrations where the maximal response is not If (i.e., a peak response
exists). When plotted against agonist concentration, the degree of desen-
sitization can be fitted with an empirical equation of the Hill form:
Degree of desensitization Dmin
Dmax Dmin
1 agonistCD1/2 
nD
(4)
where CD1/2 is the concentration at which the degree of desensitization is
half maximal. Dmax and Dmin are the maximal and minimal degrees of
desensitization, respectively. nD is the Hill coefficient indicative of the
slope of the degree-of-desensitization relationship. Errors are standard
deviations of the mean.
Simulations and fitting models to data
Whole-cell currents under voltage clamp were simulated by numerical
calculations of the probability to occupy open states as described previ-
ously (Benveniste et al., 1990). This program was originally written by Dr.
J. D. Clements and extensively modified by Benveniste. Exchange between
solution conditions was modeled with a 10-ms exchange time constant for
all simulations. Parameters for models 1 and 2 (see Fig. 3) were determined
by fitting these models simultaneously to average normalized peak and
final amplitude data sets as well as the degree-of-desensitization data set.
Because the degree of desensitization is theoretically derived from Ip and
If, inclusion of this data set in the fitting procedure may seem redundant.
However, the degree-of-desensitization values were determined indepen-
dently for each data trace and do not result from utilizing average Ip and If
values of Fig. 2 C in Eq. 3. In practice, addition of this data set limited the
number of solution sets. Model parameters were estimated iteratively
utilizing a Simplex algorthim (Press et al., 1992), and the error function
was the summation of the square of the difference between the model
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estimates and the three data sets (sum squared error (SSE)). The only
parameters that were allowed to freely vary during the fitting procedure
were k1off, k2off, k3off, and k5on (see Table 2). The data could not be
successfully fit with the addition of more freely variable parameters. The
following parameters remained constant during the fit, but their values
were varied systematically between fits: k1on, k3on, and k5off. Simulations
were conducted on a Power Macintosh G3 computer.
RESULTS
Degree of desensitization decreases as the
background concentration of
glutamate is increased
Applying a pulse of nearly saturating NMDA (300 M) in
the continual presence of glycine to rat cultured hippocam-
pal neurons, elicited NMDA receptor currents that peaked
and desensitized (Fig. 1 A). Ip and If measured during the
NMDA pulse increased when the pre-equilibrated back-
ground concentration of glycine was increased; however, Ip
tended toward saturation at lower background concentra-
tions of glycine in comparison with those required for
saturation of If (Fig. 1 A). This suggests that the affinity for
glycine binding at Ip may be higher than that at If. The
degree of desensitization (Eq. 3) gradually decreases from
64.9  6.3% for responses in which no background con-
centration of glycine was added (endogenous levels) to
41.2  8.2% (n  13 cells) in which 10 M glycine was
added (Fig. 1 B). Desensitization of currents elicited by 100
M NMDA in the continual presence of various concentra-
FIGURE 1 NMDA receptors exhibit desensitization whose degree depends on the background concentration of either glycine or glutamate. (A) In the
same hippocampal neuron, 300 M NMDA was pulsed for 1.5 s in the continual presence of a background concentration of 0.1, 1, or 10 M (saturating)
added glycine. Current responses desensitized 72.7%, 39.6%, and 37.5%, respectively, indicating a dependence on glycine concentration. (B) Plot of the
degree of desensitization with changing background glycine concentration. Ip and If data were extracted from experiments like that depicted in A and
subjected to Eq. 3 and show a decreasing degree of desensitization with increasing glycine concentration. Endo indicates the degree of desensitization
observed for a 300 M NMDA pulse with no added (endogenous) glycine. (C) When either 1 or 10 M (saturating) glutamate was pulsed in the continual
presence of a 10 M background concentration of glycine, only the 10 M glutamate response desensitized (27%). The 1 M glutamate response nearly
reached equilibrium at the end of the 1.5-s glutamate pulse. (D) When glutamate and 10 mM 5MeI2CA were pre-equilibrated with neurons before pulsing
with 1 mM L-alanine, NMDA receptor responses desensitized. Current traces are from three different cells whose amplitudes have been normalized to the
10 M glutamate response shown. Currents desensitized 75.1, 68.0, 41.0, and 12.6% for 0.1, 0.3, 1, and 10 M glutamate. The time gap symbolized by
the double backslash is 800 ms.
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tions of glycine has been characterized on cultured mouse
neurons in more detail previously (Vyklicky et al., 1990).
We wished to determine whether NMDA receptor re-
sponses would desensitize to differing degrees by variation
of glutamate agonist concentration while the glycine back-
ground concentration was held constant near saturation.
When applying a pulse of glutamate at concentrations 1
M in the continual presence of 10 M glycine, peak
currents were observed within the first 500 ms of glutamate
application (Fig. 1 C). For glutamate concentrations 1
M, NMDA receptor responses increased slowly, such that
the maximum amplitude observed during the glutamate
application was If (Figs. 1 C and 2 A). The slow rise in
NMDA receptor currents observed at these glutamate con-
centrations probably results from a slow association rate for
glutamate binding at low glutamate concentrations. Such a
problem can be alleviated by conducting the converse ex-
periment to that of Fig. 1 A.
A given constant background concentration of glutamate
in the absence of added glycine is allowed to pre-equilibrate
with NMDA receptors before their activation with a pulse of
a saturating concentration of L-alanine (1 mM), a low-
affinity glycine agonist (Fig. 1 D). A rapid rise in the
NMDA receptor response was observed when a solution of
FIGURE 2 Dose-response analysis of desensitizing NMDA receptor responses modulated by glutamate. (A) Ip (E) and If (F) response amplitudes were
measured for NMDA currents elicited with various concentrations of glutamate in the continual presence of 10 M glycine. Analysis of responses according
to Eq. 2 yielded an EC50 value of 4.3  0.4 M and Hill coefficient of 1.2  0.1 for the Ip curve, and an EC50 value of 2.8  0.4 M and Hill coefficient
of 1.2  0.1 for the If curve (n  14 cells). (B) The degree of desensitization defined by Eq. 3 is plotted with respect to glutamate concentration. Only
positive values derived from Eq. 3 are plotted. The plot indicates that desensitization increases as glutamate concentration increases. (C) Ip (E) and If (F)
dose response curves derived from experiments in which 1 mM L-alanine was pulsed in the continual presence of various background concentrations of
glutamate. The Ip EC50 was 0.9  0.1 M with an nH of 0.60  0.03. The If EC50 was 1.7  0.3 M with an nH of 0.9  0.1. Imax values for Ip and If
curves were 123.4  2.6 and 83.1  2.8%, respectively. (D) The degree-of-desensitization plot for the experiment depicted in C yielded a CD1/2 value of
2.3  0.7 M, an nD of 1.8  0.6, and Dmax and Dmin values of 63.7  2.6% and 28.0  2.2%, respectively.
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1 mM L-alanine and a given background concentration of
glutamate replaced a solution containing 10 mM 5MeI2CA,
and the same background concentration of glutamate.
5MeI2CA was used to inhibit NMDA receptor responses
when glutamate was applied alone (see Materials and Meth-
ods). Desensitization of the peak current was observed for
all background glutamate concentrations used (Fig. 1 D);
however, the degree of desensitization was markedly lower
for background concentrations 	10 M glutamate than for
concentrations 3 M glutamate (Fig. 2 D).
Dose-response analysis of Ip and If for glutamate pulsed
at various concentrations in the continual presence of a
background concentration of 10 M glycine (Fig. 1 C)
yielded EC50 values of 4.3  0.4 M and 2.8  0.4 M,
respectively (Fig. 2 A), and Hill coefficients for both Ip and
If  1.2  0.1 (n  14 cells). At glutamate pulse concen-
trations1 M, the concentration-dependent association of
glutamate with NMDA receptors seems to be slower than
the kinetics of desensitization, such that no peak currents
were observed (Figs. 1 C and 2 A). Fig. 2 B indicates that the
degree of desensitization increased with increasing gluta-
mate concentration for those concentrations at which a peak
current could be observed (1 M).
When a given concentration of glutamate was applied
continuously throughout the experiment and a pulse of 1
mM L-alanine applied to elicit NMDA receptor activation
(Fig. 1 D), Ip and If dose-response curves did not generally
overlap (Fig. 2 C). Analysis of Ip and If yielded a small but
significant difference in EC50 values: 0.9  0.4 M for Ip
and 1.7  0.3 M for If (n  53 cells; p  0.0001). The
degree of desensitization measured from currents elicited
with this protocol decreased as the background concentra-
tion of glutamate increased (Fig. 2 D). This is in contrast to
the observed increase in the degree of desensitization as the
concentration of glutamate increases during the glutamate
pulse protocol (Fig. 2 B). The data in Fig. 2 D were fit with
Eq. 4 to yield a CD1/2 value of 2.3  0.7 M with a nD of
1.8  0.6 and limiting desensitization levels of 63.7  2.6
and 28.0  2.2% for Dmax and Dmin, respectively (n  53
cells).
Simulations of changes in the degree of
desensitization with changing
glutamate concentration
Because less than a twofold increase in EC50 values was
observed between Ip and If data in Fig. 2 C, we were not
convinced that desensitization observed when 1 mM L-
alanine was pulsed in the continual presence of glutamate
reflected a mechanism in which glutamate affinity is weak-
ened upon glycine agonist binding and channel activation.
Other desensitization mechanisms are known to exist
(Krupp et al., 1996, 1998, 1999; Legendre et al., 1993;
Medina et al., 1995; Sather et al., 1990; Tong and Jahr,
1994). In general, these desensitization phenomena can be
described by agonist-bound receptors that enter a long-lived
(desensitized) state from which channel activation is not
directly possible (i.e., transition 5 in Fig. 3). Such desensi-
tization mechanisms might reduce or mask a shift in gluta-
mate affinities that otherwise would be observed by analysis
of Ip and If dose-response curves. To test this possibility
theoretically, two cyclic models containing two binding
sites each for glutamate and glycine agonists were used for
simulating NMDA receptor responses (Fig. 3, A and B).
Previous studies have suggested that the binding of two
molecules of a glycine agonist and two molecules of a
FIGURE 3 Reaction schemes for two models containing two binding
sites for each agonist. Model 1 (A) and model 2 (B) require the binding of
two molecules of glutamate (G) and L-alanine (A) to reach a fully liganded
state (G2RA2), which leads to the open state (G2R*A2) of the channel. The
G2R	A2 state is the long-lived nonconducting state. The two models differ
in their placement of equivalent reactions. Kn represents the equilibrium
dissociation constant for equivalent transition type n. Model 1 has six
high-affinity agonist-binding macroscopic transitions and six low-affinity
agonist-binding macroscopic transitions; whereas model 2 has all high-
affinity agonist-binding macroscopic transitions except for the two transi-
tions closest to the fully liganded state. Boxed Kn values emphasize the
transitions that differ in their equivalent transition type between the two
models. Kinetic parameters utilized for these two models can be found in
Tables 1 and 2.
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glutamate agonist are required for channel opening (Ben-
veniste et al., 1990; Benveniste and Mayer, 1991; Clements
and Westbrook, 1991; Clements and Westbrook, 1994;
Rosenmund et al., 1998). These models could simulate
desensitization resulting from channels in which agonist
affinities weaken upon binding of the co-agonist by setting
K3K1 and K4K2. In addition, these models also could
simulate desensitization resulting from channels in the fully
liganded state that enter a long-lived closed state (G2R’A2 in
Fig. 3).
In Fig. 4, Ip, If, and the degree of desensitization are
analyzed for model 1 in which the K5 transition kinetics are
altered while the agonist-binding transitions are not weak-
ened by the binding of co-agonist (i.e., K3  K1 and K4 
K2). The kinetic rate constants of the transitions for gluta-
mate binding, channel opening, and the transition into the
desensitized state are based on measurements and analysis
of NMDA EPSC data utilizing a two-equivalent-site model
(Lester and Jahr, 1992). Rate constants for L-alanine were
also determined previously (Benveniste and Mayer, 1991).
Rate constants for these simulations are presented in Table
1. The simulated protocol is similar to the experimental
protocol utilized in Fig. 1 D, in which the cell is pre-
equilibrated with a background concentration of glutamate
before the addition of 1 mM L-alanine. Fig. 4 A shows
simulated traces of subsaturating (1 M) and supersaturat-
ing (1 mM) background concentrations of glutamate for a
model lacking transition 5 (symbolized by the K5 equilib-
rium in Fig. 3), a model in which Dmax is similar to that of
experimental data (Fig. 2 D), and a model in which Dmax is
85%. Dmax was increased by reducing the rate of return
from the desensitized state (koff, transition 5; see Table 1).
All simulations were done with the same number of chan-
nels, thus allowing direct comparison of Ip and If between
FIGURE 4 Effects of desensitization caused by transition 5 on standard
dose-response analysis of models with a single binding affinity for gluta-
mate and L-alanine. Model 1 (Fig. 3 A) has been used to simulate NMDA
responses resulting from a 1 mM pulse of L-alanine in the continual
presence of a given background concentration of glutamate. In all three
simulations depicted, models contain a single binding affinity for glutamate
and L-alanine such that K1  K3 and K2  K4. All kinetic parameters are
presented in Table 1. (A) Simulated currents resulting from three versions
of model 1. The left panel contains simulations in which transition 5 had
been removed. The middle panel contains simulations in which transition
5 had a koff value of 9.4 s
1, which yielded a moderate level of desensi-
tization (34%) when the background glutamate concentration was saturat-
ing. The right panel contains simulations in which transition 5 had a koff
value of 1.0 s
1, which yielded considerable desensitization (86%) when
the background glutamate concentration was saturating. Thin and thick
lines depict currents in which the background concentration of glutamate
was either 1 mM or 1 M, respectively. Arrows emphasize the slow rise of
the current in response to the application of 1 mM L-alanine. (B) Ip (open
symbols) and If (filled symbols) dose-response curves for transition 5
containing models. Circles and squares represent simulations done at
discrete glutamate concentrations utilizing the versions of model 1 whose
currents are depicted in the middle and right panels of A, respectively.
Smooth lines indicate the fits to Eq. 2. The model depicted in the middle
panel of A yielded the following fit parameters: EC50  2.6  0.1 M,
nH  1.1  0.1, and Imax  120.6  1.0% for the Ip curve; and EC50 
1.22 0.03 M, nH 1.4 0.03, and Imax 79.1 0.5% for the If curve
(E and F). The model shown in the right panel of A yielded the following
fit parameters: EC50  2.9  0.1 M, nH  1.3  0.02, and Imax 
120.6  0.4 for Ip data; and EC50  0.44  0.01 M, nH  1.7  0.1, and
Imax  17.0  0.1% for the If data ( and f). (C) Plot of the degree of
desensitization with respect to glutamate concentration for data resulting
from the model utilized in the middle panel (E) or right panel of A ().
Data points are connected by lines to emphasize the trend of an increasing
degree of desensitization with an increasing concentration of background
glutamate. Only positive values calculated from Eq. 3 for the degree of
desensitization are depicted.
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each of the three models shown (Fig. 4 A). When transition
5 was omitted, simulated responses did not desensitize (Fig.
4 A, left panel), and the magnitude of the response was
greater than when transition 5 was included in model 1 (Fig.
4 A, middle and right panels). Responses in which a peak
current was observed were at glutamate concentrations of
1–3 M (Fig. 4 B). At lower background glutamate con-
centrations, the rise in the simulated responses had a slow
phase (arrows, Fig. 4 A), such that Ip measured within the
first 500 ms of L-alanine application wasIf (Fig. 4 B). The
slow rise in the simulated response at these concentrations
was unexpected because the background glutamate concen-
trations are pre-equilibrated with their receptors before the 1
mM L-alanine application. For the two simulations in which
transition 5 was included, the degree of desensitization
increased as glutamate concentrations were increased (Fig.
4 C). Similar trends were also observed for model 2 (data
not shown).
To simulate desensitization caused by a weakening of
agonist affinity, model 1 was set such that K3 was fourfold
greater than K1 (and hence K4 was fourfold greater than K2)
for the following simulations. As in Fig. 4, background
concentrations of 1 M and 1 mM glutamate were pre-
equilibrated with their binding sites before application of 1
mM L-alanine (Fig. 5 A). The number of channels is equiv-
alent to that used in Fig. 4 to allow direct comparison
between the models. When transition 5 was omitted, it can
be observed that responses to L-alanine in the presence of
saturating glutamate (1 mM) did not desensitize (Fig. 5 A,
left panel). Yet when a subsaturating background concen-
tration of 1 M glutamate was used, the response desensi-
tized 38%. In fact, Ip was greater than If for all background
glutamate concentrations 30 nM (Fig. 5 B). In addition, a
rightward shift between Ip and If dose-response curves is
readily apparent (Fig. 5 B). Dose-response analysis accord-
ing to Eq. 2 for the version of model 1 lacking transition 5
yielded EC50 values of 1.1 and 1.9 M for Ip and If curves,
respectively. Respective Hill coefficients were 1.0 and 1.3.
Similar trends were observed in simulations utilizing model
2 (data not shown). The degree of desensitization calculated
from Ip and If for this version of model 1 was analyzed by
Eq. 4. The CD1/2 value was 1.8 M with a Hill coefficient
nD of 1.4. Dmin and Dmax values were 0% and 84.3%,
respectively. Note that in this simulation (Fig. 5 A, left
panel), the maximum degree of desensitization (Dmax) is
observed at low glutamate concentrations (Fig. 5 C),
whereas in the simulations presented in Fig. 4, Dmax was
observed at saturating background glutamate concentrations.
The version of model 1 that contained the fourfold dif-
ference between K1 and K3 (or K2 and K4) was then mod-
ified to include transition 5 to characterize the effects of
inclusion of both types of desensitization mechanisms on
the dose-response analysis. By comparing Fig. 4 A with Fig.
5 A, it can be observed that for a saturating concentration of
glutamate (1 mM), the simulated responses overlap. How-
ever, in contrast to Fig. 4 A, all subsaturating responses did
peak within the first 500 ms of the response (Fig. 5 A).
Dose-response analysis of data from the simulation in which
1 mM glutamate yielded a moderate degree of desensitiza-
tion (Fig. 5 A, middle panel) produced EC50 values of 1.0
and 1.2 M with Hill coefficients of 1.1 and 1.4 for Ip and
If, respectively. The degree of desensitization for this sim-
TABLE 1 Rate constants for simulations of NMDA receptor activation utilizing model 1
Transition* Agonist kon (M
1 s
1) koff (s
1) koff/kon
1 Glutamate
Fig. 4 5.0† 6.7‡ 1.3 M
Fig. 5 5.0† 1.68 0.34 M
Fig. 6 5.0† 0.84, 1.68, 3.36 0.17, 0.34, 0.67 M
2 L-Alanine
Fig. 4 1.7§ 19.9§ 11.7 M
Fig. 5 1.7§ 2.48, 4.95, 9.95 1.46, 2.91, 5.85 M
3 Glutamate
Figs. 4–6 5.0† 6.7‡ 1.3 M
4 L-Alanine
Figs. 4–6 1.7§ 19.9§ 11.7 M
5¶ Agonist independent
Figs. 4 and 5 15.2‡ 1.0, 9.4‡ 0.07, 0.62
Fig. 6 15.2‡ 1, 2, 4, 8, 16, 32 0.07, 0.13, 0.26, 0.53,
1.05, 2.11
6 Agonist independent
Figs. 4–6 83.8‡ 83.8‡ 1.0
*Equivalent transition types are numbered according to the scheme depicted in Fig. 3 A (model 1).
†Taken from Clements and Westbrook (1991).
‡Taken from NMDA EPSC data of Lester and Jahr (1992).
§Taken from Benveniste and Mayer (1991).
¶This transition is omitted in the simulations presented in the left panel of Figs. 4 A and 5 A.
Agonist-independent kon are in units of s
1.
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ulation also decreased with increasing glutamate concentra-
tion. Analysis utilizing Eq. 4 yielded a CD1/2 value of 0.4
M with a Hill coefficient nD of 1.6. Dmin and Dmax values
were 32.4% and 82.3%, respectively.
Strongly desensitized responses observed from simula-
tions with a saturating concentration of glutamate (Fig. 5 A,
right panel) result from accumulation of receptors in a
high-affinity desensitized state (i.e., G2R	A2 in Fig. 3). In
such a model, the increase in EC50 values between Ip and If
is lost (Fig. 5 B), and there is no consistent decrease in the
degree of desensitization with increasing glutamate concen-
tration (Fig. 5 C). Note that for the strongly desensitizing
model (Fig. 5 A, right panel) the EC50 value for Ip (1.0 M)
was greater than that for If (0.4 M). This contrasts with the
experimental result found for Ip and If from the glutamate
dose response curves (Fig. 2 C).
The difference between EC50 values determined from Ip
and If dose-response curves for models where K1  K3 (and
K2  K4) decreases as the desensitized state, G2R	A2, is
stabilized by decreasing K5 (Table 1 and Fig. 6 A). The
degree of difference between EC50 values for Ip and If
curves is also model dependent and always underestimates
the true difference between high and low agonist binding
affinities. When transition 5 does not exist, model 1 yields
a 1.7-fold difference between Ip and If EC50 values, whereas
model 2 produces a 1.4-fold difference, even though the
ratio of K3 to K1 is fourfold (Fig. 6 A). When transition 5 is
FIGURE 5 Effects of desensitization caused by transition 5 on standard
dose-response analysis of models containing high and low agonist affinities
for glutamate and L-alanine. Model 1 (Fig. 3 A) was used to simulate
NMDA responses resulting from a 1 mM pulse of L-alanine in the continual
presence of a given background concentration of glutamate. In all three
simulations depicted, models contain a fourfold difference between high-
and low-affinity binding transitions for glutamate and L-alanine such that
4K1  K3 and 4K2  K4. All kinetic parameters are presented in Table 1.
(A) Simulated currents resulting from three versions of model 1. The left
panel contains simulations in which transition 5 had been removed. The
middle panel contains simulations in which transition 5 had a koff value of
9.4 s
1, and the right panel contains simulations in which transition 5 had
a koff value of 1.0 s
1. Thin and thick lines depict currents in which
the background concentration of glutamate was either 1 mM or 1 M,
respectively. Dashed lines depict the same responses to 1 M glutamate
shown in Fig. 4 A with K1  K3 and K2  K4. Currents resulting from
simulation of models in Fig. 4 with 1 mM glutamate and 1 mM L-alanine
were identical to thin lined responses shown here. (B) Ip (open symbols)
and If (filled symbols) dose-response curves for the models whose simu-
lations are presented in A. Circles, squares, and triangles represent simu-
lations done at discrete glutamate concentrations utilizing the versions of
model 1 whose currents are depicted in the left, middle, and right panels of
A, respectively. Following are the parameters from fits to Eq. 2 (smooth
lines). For the model not containing transition 5, fit parameters for Ip data
were EC50  1.1  0.1 M, nH  1.0  0.1, and Imax  113.3  1.2%;
fit parameters for If data were EC50 1.9 0.1 M, nH 1.3 0.04, and
Imax  113.4  0.7% (E and F). For the model depicted in the middle
panel of A, fit parameters for Ip data were EC50  1.0  0.1 M, nH 
1.1 0.1, and Imax 113.3 1.1%; fit parameters for If data were EC50
1.2  0.03 M, nH  1.4  0.1, and Imax  74.1  0.4% ( and f). For
the model depicted in the right panel of A, fit parameters for Ip data were
EC50  1.0  0.1 M, nH  1.1  0.1, and Imax  111.3  1.1%; fit
parameters for If were EC50  0.4  0.01 M, nH  1.7  0.04, and
Imax  15.9  0.1% (‚ and Œ). (C) Plot of the degree of desensitization
with respect to glutamate concentration for the three versions of model 1
examined in A. Fits to Eq. 4 are depicted by smooth lines. Open circles
depict analysis done for the model represented in the left panel of A in
which transition 5 has been omitted. Fit parameters for this simulation were
CD1/2  0.8  0.03 M, nD  1.4  0.1, Dmax  84.4  0.8%, and
Dmin 0.0%. Open squares depict analysis done for the model represented
in the middle panel of A. Fit parameters for this simulation were CD1/2 
0.4  0.1 M, nD  1.6  0.2, Dmax  82.3  1.1%, and Dmin  32.4 
0.6%. Open triangles depict analysis done for the model represented in the
right panel of A. This data could not be fit with Eq. 4.
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included in these models, no difference between Ip and If
EC50 values is observed if the degree of desensitization to a
saturating concentration of glutamate reaches 48.1% and
30.2% for models 1 and 2, respectively (Fig. 6 A).
Comparison of the degree of desensitization
modulated by glutamate to that of glycine
Fig. 5 C shows that analysis of simulated currents from
different versions of model 1 yielded vastly different de-
grees of desensitization at saturating concentrations of glu-
tamate. However, when background concentrations of glu-
tamate were low (30 nM), the degrees of desensitization
found for all three versions of model 1 were all 80% (Fig.
5 C). One parameter that remained constant between the
three simulations depicted in Fig. 5 C was the fourfold
difference between K1 and K3. Thus, we reasoned that the
degree of desensitization observed at low glutamate con-
centrations (30 nM) may be indicative of the difference in
agonist-binding affinities represented by K1 and K3 (or K2
and K4).
To test this, the degree of desensitization was measured
for simulated currents resulting from the application of 1
mM L-alanine in the continual presence of a background
concentration of either 30 nM or 1 mM glutamate. The rate
of return from the long-lived desensitized state in transition
5 was varied for models containing a twofold, fourfold, and
eightfold difference in agonist-binding affinities (K1 com-
pared with K3 or K2 compared with K4; see Table 1). Results
from these simulations indicate that the degree of desensi-
tization at low glutamate concentrations did not vary greatly
with the degree of desensitization observed at maximal
glutamate concentrations (Fig. 6 B). In addition, the degree
of desensitization observed at low glutamate concentrations
correlated with the degree of the affinity shift between the
two agonist-binding states. For example, a twofold differ-
ence between K1 and K3 in model 1 yielded 35–40%
desensitization of the peak response when 30 nM glutamate
was the background concentration; yet, a fourfold differ-
ence between K1 and K3 yielded approximately an 80%
degree of desensitization (Fig. 6 B). However, note that the
correlation between shifts in agonist affinity and the degree
of desensitization at low concentrations of glutamate was
model dependent. The degree of desensitization of experi-
mental data acquired from a 1 mM pulse of L-alanine with
a background concentration of 30 nM glutamate (Fig. 2 D)
falls on the simulated curve for model 2, which contains a
fourfold shift in glutamate affinities (Fig. 6 B). The real data
also falls between the curves for model 1 containing either
a twofold or fourfold difference in glutamate affinities.
FIGURE 6 Prediction of agonist affinity shifts from dose-response anal-
ysis. (A) Ratio of EC50 values derived from Ip and If dose-response curves
is plotted with respect to the degree of desensitization observed when the
background concentration of glutamate is saturating. The versions of model
1 (f, see Fig. 3 A) and model 2 (, see Fig. 3 B) utilized for these
simulations contained mechanisms for both types of desensitization, like
those utilized in Fig. 5. K3 was equal to 4K1, and K4 was equal to 4K2. koff
for transition 5 was varied as shown in Table 1 to yield varying degrees of
desensitization when the background glutamate concentration was maxi-
mal. The difference between Ip and If EC50 values dissipates as the degree
of desensitization observed at a background concentration of 1 mM glu-
tamate increases. The dashed horizontal line indicates the point at which
there is no difference between Ip and If EC50 values. The ratio of EC50
values versus the degree of desensitization derived from experimental data
for glutamate (Fig. 2, C and D) is indicated by the cross-marker. (B)
Analysis of the degree of desensitization at low and high background
agonist concentrations. Models 1 and 2 were simulated utilizing a 1 mM
L-alanine pulse and either a 30 nM or 1 mM background concentration of
glutamate. The degree of desensitization of the 30 nM glutamate response
was plotted against the 1 mM glutamate response for models in which the
koff of transition 5 was varied according to Table 1. This procedure was
repeated for various ratios of K1:K3 (or K2:K4). Depicted are ratios of 1:2
for model 1 (F), 1:4 for model 1 (f), 1:4 for model 2 (), and 1:8 for
model 2 (‚). Experimental data for glutamate derived from Fig. 2 D is also
included for comparison (). Because these models are symmetric, iden-
tical data will result from simulations in which glycine is the background
agonist, present at either 30 nM or 10 M concentrations with 300 M
NMDA being pulsed to elicit NMDA receptor responses. Experimental
data for glycine derived from analysis of desensitization under these
conditions was taken from Fig. 1 B and also included for comparison (v).
2160 Nahum-Levy et al.
Biophysical Journal 80(5) 2152–2166
For both models presented (Fig. 3), shifts in glutamate
agonist affinities must be equivalent to shifts in glycine
agonist affinity. Thus, Fig. 6 B can also be used to describe
simulations in which 300 M NMDA is pulsed in the
continual presence of very low (30 nM) and saturating (10
M) background concentrations of glycine. The degree of
desensitization for 30 nM glycine determined from experi-
mental data (Fig. 1 B) was similar to the degree of desen-
sitization for 30 nM glutamate (Fig. 6 B) and suggests that
the ratio of the low- and high-affinity states for glycine
(K4/K2) may be similar to that of glutamate (K3/K1).
Fitting of glutamate dose-response data to
models 1 and 2
Although analysis in Fig. 6 B indicates that the shift be-
tween high- and low-affinity states for glutamate binding
may be three- to fourfold, these simulations were based on
systematic variation of some of the rate constants (K1, K3,
and K5) whereas other rate constants (K2, K4, and K6) were
taken from the literature (Table 1). A better approach would
be to search the parameter space by fitting the experimental
data with models 1 and 2. Such an approach has been used
previously for determining affinity shifts for desensitization
modulated by glycine (Benveniste et al., 1990). We at-
tempted to fit a prototypical raw data set composed of
activation, desensitization, and deactivation kinetics ob-
served in response to a pulse of 1 mM L-alanine in the
continual presence of various background concentrations of
glutamate with models 1 and 2. However, the kinetics of the
decrease in current from Ip to If varied too greatly from cell
to cell for us to determine whether one or two exponentials
would best describe the current decay and prevented us
from determining the decay time constant(s). Instead, the
data sets of average Ip and If (Fig. 2 C) and the degree-of-
desensitization data set (Fig. 2 D) were simultaneously fit
with predicted values from each model.
All solution sets to the fitting procedure indicated that
model 2 fit the data better than model 1 because model 2
had approximately a 1.5-fold lower SSE than model 1 (Fig.
7 A). All solution sets for a particular model yielded similar
ratios between the low- and high-affinity states for gluta-
mate binding. Model 1 yielded a ratio of K3/K1 of 3.4,
whereas model 2 had a K3/K1 ratio of 8.8-fold (Fig. 7 A).
These values were somewhat larger than the estimates from
the simulations determined from Fig. 6 B.
The koff values for transition types 1 and 3 were heavily
dependent on the kon values for those transitions. Therefore,
the parameters from each solution set resulting from the fits
described above were used in simulations of glutamate
pulse experiments (Figs. 1 C and 2 A). The rising and
decaying phases of current resulting from the addition and
removal of glutamate in the continual presence of saturating
glycine agonist could be compared with experimental data
(Fig. 1 C). The rising phase was approximated with a
single-exponential function for glutamate concentrations of
0.1–3 M. A kon value of 4 M
1 s
1 in model 2 yielded
simulated responses whose 1/on analysis reasonably over-
laid the experimental data (Fig. 7 F). The decaying phase of
the NMDA receptor response measured upon removal of
glutamate could not be fit with a single-exponential func-
tion. Analysis utilizing the sum of two exponential func-
tions yielded slow and fast time constants (Fig. 7 F) with
approximately equal contributions (amplitude data not
shown). The rate constants for entry and exit from the
long-lived desensitized state (transition 5) also indirectly
affected the rate constants for glutamate dissociation. To
limit the number of free parameters during the fit, k5off was
held constant during the fitting procedure, but these con-
stant values were varied systematically between fits. Fits
utilizing model 2 in which k5off was fixed at 3.0 s
1 yielded
the best overlay of the glutamate dissociation data (Fig. 7
F). Optimal fit parameters for model 2 are presented in
Table 2, and their use in the simulation of desensitization
resulting from a 1 mM L-alanine pulse with a given con-
centration of background glutamate (Fig. 7 B) is comparable
to the experimental data (Figs. 1 D and 7).
Fitting of LCSS dose-response data to
models 1 and 2
Finally, we wished to determine the magnitude of the ago-
nist affinity shift when a different agonist was substituted
for the background concentration of glutamate. L-Cysteine-
S-sulfate (LCSS) was chosen as the glutamate agonist be-
cause it has apparent dissociation kinetics that can be mea-
sured with the whole-cell rapid perfusion system but has a
3.6-fold lower EC50 in comparison with glutamate (Patneau
and Mayer, 1990). Ip and If dose-response curves (Fig. 8 A)
measured in response to 1 mM L-alanine in the continual
presence of a given background concentration of LCSS
yielded EC50 values of 4.5  1.5 and 4.8  0.9 M, Hill
coefficients of 0.5  0.1 and 0.8  0.1, and Imax values of
116.4 7.4% and 79.5 3.6%, respectively (n 30 cells).
As expected, the degree of desensitization decreased with
increasing background concentrations of LCSS, suggesting
that a high and low LCSS affinity state may be present (Fig.
8 B). Analysis of the degree of desensitization with Eq. 4
yielded a Dmax and Dmin of 58.1  3.4 and 26.0  2.6%,
respectively with a CD1/2 of 2.6  1.0 M (fit not shown).
The slope of the desensitization data was steep such that an
accurate Hill coefficient could not be determined for the
limited number of data points falling in that region. For this
reason, nD was constrained to 2.
The LCSS data presented in Fig. 8 were fit with models
1 and 2 utilizing Ip, If, and degree-of-desensitization data
sets. As in the case of glutamate, fitting of the LCSS data
yielded a 33% lower SSE for model 2 in comparison with
model 1. On average, fitting to model 1 yielded a low to
high binding affinity ratio (K3/K1) of 2.8 for LCSS, whereas
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FIGURE 7 Fitting of glutamate dose-response and desensitization data to models 1 and 2. The best fits of glutamate data were obtained by simultaneous
fitting of Ip, If, and degree-of-desensitization data. The fitted parameters were then utilized in other simulations to determine their overall applicability to
the experimental data. (A) Comparison of fits of model 1 and model 2 indicated that model 2 had a lower SSE (left panel). The right panel indicates that
the ratio of KD values for low (KDLow) and high (KDHigh) affinity states for each agonist (K3/K1 or K4/K2) is also different between the two models. (B)
Simulated currents of the best fit for model 2, which also yielded good overlap between simulations and experimental data presented in E and F. Fitted
parameters can be found in Table 2. Background concentrations of glutamate depicted are 0.1, 0.3, 1, 3, 10, 30, 100, and 1000 M (C) Overlay of
experimental dose-response data for Ip and If (from Fig. 2 C) with the best fit of simulated Ip and If determined for model 2 (smooth lines). (D) Overlay
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fitting with model 2 yielded a ratio of 6.3 between the two
binding affinity states (Table 2). Interestingly, when con-
straining the koff values for L-alanine to those determined
from fitting glutamate data (Table 2) and then refitting the
data in Fig. 8, the SSE was only 18% higher than without
this added constraint and yields a fit of the degree of
desensitization that still overlays experimental data (Fig. 8
B). Under these constrained conditions, k1off and k3off were
1.41 and 12.0 s
1, respectively.
DISCUSSION
The mechanistic connection between glutamate and glycine
binding and NMDA receptor channel opening is poorly
understood. Changes induced by glutamate agonist binding
must trigger channel opening and may also weaken glycine
binding site affinity (Benveniste et al., 1990; Vyklicky et
al., 1990). The purpose of this study was to discern to what
extent a similar weakening of glutamate binding affinity
may occur. Addressing this problem can help us to under-
stand whether glutamate and glycine agonists play symmet-
ric or differential roles in the process of NMDA receptor
activation.
Assaying for agonist affinity shifts by measuring
desensitization of macroscopic currents
Two types of desensitization have been characterized for
NMDA receptors. Desensitization of macroscopic currents
in the presence of saturating concentrations of glutamate
and glycine agonists has been described as glycine-indepen-
dent or glycine-insensitive. This type of desensitization can
be subdivided into calcium dependent (Krupp et al., 1996,
1999; Legendre et al., 1993; Medina et al., 1995) and
independent components (Sather et al., 1990; Tong and
Jahr, 1994), and key residues in the NR2 subunit control its
magnitude (Krupp et al., 1998). Previously (Lester and Jahr,
1992), and in this paper (Fig. 3), this type of desensitization
was modeled as entry of the channel into a relatively long-
lived nonconducting state (i.e., transition 5).
A second type of desensitization could also be observed
when glycine concentrations were subsaturating (Lerma et
al., 1990; Vyklicky et al., 1990). The degree of desensiti-
zation elicited by an NMDA pulse decreased with an in-
creasing background concentration of subsaturating glycine
(Fig. 1 B). This type of desensitization could result if
activation of NMDA receptors resulted in a weakening of
glycine binding affinity (Benveniste et al., 1990). This af-
finity decrease causes glycine to re-equilibrate with its
receptor at its lower affinity, thus lowering glycine binding
site occupancy. In Fig. 2 D we show that the degree of
desensitization of NMDA receptor responses to a pulse of
L-alanine decreases as the concentration of glutamate in-
creases between 3 and 100 M. This may suggest that the
glutamate binding affinity is also weakened upon activation
of NMDA receptors.
To observe desensitization that can be attributed to a
weakening of agonist binding affinity, the time constant of
agonist re-equilibration with its low-affinity binding state
after NMDA receptor activation (re), must be several-fold
larger than the time constant for solution exchange around
of experimental degree-of-desensitization data (from Fig. 2D) with the best-fit parameters for simulated data using model 2. (E) Overlay of the experimental
data for initial and steady-state pulse amplitudes from the glutamate pulse protocol (from Fig. 2 A) with the best-fit parameters for model 2. (F) The rising
and declining phases of currents resulting from a glutamate pulse protocol (Fig. 1 C) were measured with one or two exponential time constants (),
respectively. These values are compared with simulated currents subjected to the same type of analysis. Œ, 1/ measured from the rise in current from
experimental data; , 1/ measured from the rise in current from simulated data utilizing the best fit from model 2; E, 1/fast measured from the decay in
current from experimental data; , 1/fast measured from the decay in current from simulated data; F, 1/slow measured from the decay in current from
experimental data; f, 1/slow measured from the decay in current from simulated data.
TABLE 2 Optimal rate constants for fitting model 2 to
experimental data presented in Figs. 7 and 8
Transition* Agonist
kon
(M
1 s
1)
koff
(s
1) koff/kon
1 Glutamate
Fig. 7 4.0† 0.97 0.24 M
1 LCSS
Fig. 8 2.0‡ 1.61 0.81 M
2 L-Alanine
Fig. 7 1.7§ 2.35 1.38 M
Fig. 8 1.7§ 3.12 1.84 M
3 Glutamate
Fig. 7 4.0† 8.25 2.06 M
3 LCSS
Fig. 8 2.0‡ 10.26 5.13 M
4 L-Alanine
Figs. 7 and 8 1.7§ 19.9§ 11.7 M
5 Agonist independent¶
Fig. 7 3.68 3.0† 0.82
Fig. 8 2.81 3.0† 1.07
6 Agonist independent¶
Figs. 7 and 8 83.8 83.8 1.0
*Equivalent transition types are numbered are according to the scheme
depicted in Fig. 3 B.
†Values were held constant during the fitting procedure but varied system-
atically between fittings.
‡This rate constant was arbitrarily chosen because no kinetic information
was available. Thus, for LCSS data, only equilibrium dissociation con-
stants (KD  koff/kon) can be compared.
§Taken from Benveniste and Mayer (1991) and held constant for all
simulations.
¶Agonist-independent kon are in units of s
1.
Taken from NMDA EPSC data of Lester and Jahr (1992) and held
constant for all simulations.
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the cell (ex). re is dependent on both the agonist associa-
tion and dissociation rates. Recalling that the agonist asso-
ciation rate is concentration dependent, observation of de-
sensitization resulting from a weakening of agonist affinity
requires that the agonist be present in low concentrations
and dissociate slowly from its binding site. Both glutamate
and glycine, which have apparent dissociation time con-
stants (off) of several hundred milliseconds, fulfill this
requirement whereas NMDA with a off of 20–40 ms
does not (Benveniste et al., 1990; Benveniste and Mayer,
1991; Lester and Jahr, 1992; Priestley and Kemp, 1994;
Sather et al., 1992).
Observation of desensitization that results from a weak-
ening of agonist affinity also requires that agonists be ap-
plied in a particular order. Examination of data in which
glutamate was pulsed with a constant background concen-
tration of glycine (Figs. 1 C and 2 A and B) indicates no
desensitization at low glutamate concentrations. In contrast,
data acquired when L-alanine was pulsed in the presence of
different background concentrations of glutamate (Figs. 1 D
and 2, C and D) indicate the presence of desensitization at
all glutamate concentrations. Glutamate must be pre-equil-
ibrated with its receptor-binding site before triggering the
molecular event that causes the rapid switch in glutamate-
binding affinity to observe this type of desensitization. If
glutamate pre-equilibration is not done (Fig. 1 C), then
channel activation kinetics, which are limited by the rate of
glutamate binding, can mask desensitization resulting from
weakening of the glutamate-binding affinity.
Significant differences in Ip and If EC50 values can be
indicative of a shift in agonist-binding affinity as has been
observed previously (Fig. 2 C and Vyklicky et al., 1990).
Analysis of Ip and If dose-response curves indicated a less
than twofold change between Ip and If EC50 values for
glutamate (Fig. 2 C) and no significant change between Ip
and If EC50 values for LCSS (Fig. 8 A). Yet, Figs. 2 D and
8 B show that the degree of desensitization decreases as
background glutamate or LCSS concentrations, respec-
tively, increase. A decrease in the degree of desensitization
with increasing background agonist concentration indicates
that a component of desensitization can be attributed to the
weakening of the background agonist binding affinity (com-
parison of Fig. 4 C with 5 C). In addition, Fig. 6 A indicates
that a large degree of desensitization observed in the pres-
ence of saturating concentrations of background agonist can
obscure differences between EC50 values for Ip and If dose-
response curves. Thus, analysis of the relationship between
the degree of desensitization and the background agonist
concentration is probably a more reliable indicator for the
existence of desensitization caused by a weakening of ag-
onist affinity than standard Ip and If dose-response analysis.
Analysis of the degree of desensitization for simulations
utilizing models in which K3 was equal to 4K1 and also
contained transition 5 (Fig. 5) yielded an interesting finding.
As expected, the degree of desensitization measured when
the concentration of background agonist was saturating
increased as the ratio of koff/kon for transition 5 decreased
(Table 1 and Fig. 5 C). However, the degree of desensiti-
zation measured when background agonist concentrations
were very low did not change with changes in the transition
5 koff/kon ratio (Table 1; Fig. 5 C). When these simulations
were run with different ratios of agonist binding affinities
(K3  2K1, K3  4K1, or K3  8K1), the degree of
desensitization observed at low background concentrations
FIGURE 8 Fits of LCSS dose-response and desensitization data to mod-
els 1 and 2. (A) Ip (E) and If (F) responses of a 1 mM pulse of L-alanine
in the presence of varying concentrations of LCSS. Responses are normal-
ized to Ip of 100 M LCSS. Simulated responses that best fit the experi-
mental data for model 2 are depicted as solid lines, and best-fit parameters
are presented in Table 2. (B) Comparison of the degree of desensitization
with respect to LCSS concentration for experimental data (E) and the best
fit using model 2 (——). Best-fit parameters for model 2 (Table 2) yielded
a 6.3-fold difference between high- and low-affinity states for agonist
binding. When L-alanine koff values were kept constant at the best-fit values
determined from fits to glutamate data (Fig. 7), the fits that resulted for
LCSS data yielded simulated degree-of-desensitization data according to
the dashed line.
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of agonist increased as the ratio of K3 to K1 (or K4 to K2)
increased (Fig. 6 B). This suggests that analysis of the
degree of desensitization when the background concentra-
tion of agonist is low could be a good experimental measure
of the ratio of high- to low-affinity agonist-binding states,
because this measure is not very sensitive to desensitization
caused by channels entering a long lived nonconducting
state.
Mechanistic implications for NMDA
receptor activation
The discovery that the degree of desensitization of NMDA
receptor responses can be dependent on glutamate concen-
tration complements earlier findings that the degree of de-
sensitization can also be dependent on glycine concentration
(Benveniste et al., 1990; Vyklicky et al., 1990). These
observations reinforce the hypotheses that such desensitiza-
tion results from a weakening of glutamate and glycine
affinity that occurs upon NMDA channel activation. For
symmetric cyclic models like those depicted in Fig. 3, the
law of microscopic reversibility (Colquhoun and Hawkes,
1995) requires that changes in the ratio of affinity states for
glutamate binding (K3/K1) must be accompanied by equiv-
alent changes in the ratio of glycine agonist binding (K4/K2).
Because the degree of desensitization measured for low
background concentrations of agonist is indicative of the
ratio of the high and low affinities of binding of that agonist,
then both glutamate and glycine should yield similar de-
grees of desensitization and hence similar high- to low-
affinity ratios, if NMDA receptors follow a cyclic, symmet-
ric reaction scheme. Fig. 6 B shows that the degree of
desensitization observed for a 1 mM pulse of L-alanine with
a background concentration of 30 nM glutamate is similar to
the degree of desensitization observed for a 300 M pulse
of NMDA with a background concentration of 30 nM
glycine. This suggests that the ratio of low- to high-affinity
glutamate binding and low- to high-affinity glycine binding
is also similar and therefore supports a cyclic symmetric
model for NMDA receptor activation.
In all trials, simultaneous fitting of Ip, If, and degree-of-
desensitization data for glutamate (Fig. 7) and LCSS (Fig.
8) yielded lower SSE values for model 2 in comparison with
model 1. This is in contrast to previously published results
for pulses of 100 M NMDA with differing background
concentrations of glycine on mouse hippocampal neurons
where a model similar to model 1 yielded the best fit
(Benveniste et al., 1990). Differences between animal spe-
cies and the type and concentration of agonists used be-
tween the two studies could possibly account for the dis-
crepancy in model preference. Yet, other differences in the
analysis done in the two studies also exist. Previously,
transitions 5 and 6 (Fig. 3) were not explicitly modeled.
Instead, the G2RA2 state was assumed to be the open state
and analysis was limited to neurons that exhibited a minimal
amount of desensitization under saturating agonist condi-
tions such that transition 5 could be neglected. It should be
noted that in this study, increasing or decreasing transition
6 koff and kon rate constants by 10-fold did change agonist
dissociation constants resulting from the fitting procedure
but not the ratio between the high-and low-affinity binding
states for each agonist (data not shown).
Mutational analysis of recombinant NMDA receptors
suggests that glutamate and glycine agonists bind at inde-
pendent receptor sites (Anson et al., 1998; Hirai et al., 1996;
Kuryatov et al., 1994; Laube et al., 1997); yet, the law of
microscopic reversibility dictates that reaction rate con-
stants in a cyclic reaction scheme for activation are not
entirely independent. According to the law of microscopic
reversibility, the ratio of microscopic KD values between
high-affinity (K1) and low-affinity (K3) binding states in a
cyclic model should be constant for any glutamate agonist if
the same glycine agonist (with constant K2 and K4 values) is
always used. In contrast, one expects that any glutamate
agonist would have its own intrinsic high- and low-affinity
KD values (K1 and K3), indicating that the ratio of K1 to K3
could vary substantially for different glutamate agonists.
This contradiction can be resolved by postulating that K2
and K4 values for a particular glycine agonist can be slightly
modified so that the ratio of K4 to K2 matches the ratio of K3
to K1 for a particular glutamate agonist. Conversely, K1 and
K3 values for a particular glutamate agonist can also be
slightly modified so that the ratio of K3 to K1 matches the
ratio K4 to K2 for a particular glycine agonist. This would
suggest that although the microscopic high- and low-affinity
binding constants for both glutamate and glycine agonists
can vary substantially, the ratio of the high- to low-affinity
binding constants will not vary greatly. The ratio of high to
low binding affinities by fitting model 2 to dose-response
and degree-of-desensitization data was 8.5 and 6.3 for glu-
tamate and LCSS, respectively (Figs. 7 and 8). These values
are not strikingly different. These data suggest that the ratios
of high to low binding affinities for glutamate and glycine
agonists are interdependent. Previously, it has been shown
that both glutamate and glycine agonist dissociation rates
depend on the co-agonist present (Priestley and Kemp,
1994). Slower glutamate dissociation was correlated with
the presence of a higher-affinity full glycine co-agonist.
Also, slower glycine dissociation was correlated with the
presence of a higher-affinity glutamate co-agonist (Priestley
and Kemp, 1994). Such a functional linkage between the
glutamate- and glycine-binding sites could result from a
direct allosteric interaction between the two binding sites or
by having common molecular elements in the pathway to
channel activation and opening. Currently, we are trying to
distinguish whether the molecular events that cause the
apparent affinity switch for agonist binding could be the act
of co-agonist binding as implied by the models illustrated
above, channel opening, and/or ion permeation.
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